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Purpose. To evaluate stent lumen visibility of a large sample of diﬀerent peripheral arterial (iliac, renal, carotid) stents using
magnetic resonance angiography in vitro. Materials and Methods.2 1d i ﬀerent stents and one stentgraft (10 nitinol, 7 316L, 2
tantalum, 1 cobalt superalloy, 1 PET + cobalt superalloy, and 1 platinum alloy) were examined in a vessel phantom (vessel
diameters ranging from 5 to 13mm) ﬁlled with a solution of Gd-DTPA. Stents were imaged at 1.5 Tesla using a T1-weighted
3D spoiled gradient-echo sequence. Image analysis was performed measuring three categories: Signal intensity in the stent lumen,
lumen visibility of the stented lumen, and homogeneity of the stented lumen. The results were classiﬁed using a 3-point scale
(good, intermediate, and poor results). Results. 7 stents showed good MR lumen visibility (4x nitinol, 2x tantalum, and 1x cobalt
superalloy). 9 stents showed intermediate results (5x nitinol, 2x 316L, 1x PET + cobalt superalloy, and 1x platinum alloy) and 6
stents showed poor results (1x nitinol, and 5x 316L). Conclusion. Stent lumen visibility varies depending on the stent material and
type. Some products show good lumen visibility which may allow the detection of stenoses inside the lumen, while other products
cause artifacts which prevent reliable evaluation of the stent lumen with this technique.
1.Introduction
Stenoses and occlusion of peripheral arterial vessels are
frequently treated with angioplasty and stent insertions.
After stent placement there is a risk of in-stent restenosis
which can be caused by neointimal growth, vessel wall
inﬂammation or stent thrombosis [1, 2]. For this reason,
follow-up examinations are needed after successful revascu-
larization therapy with stents.
Diﬀerent techniques are available for follow-up exami-
nations.Intra-arterialdigitalsubtractionangiography(DSA)
has been the standard procedure for evaluating the stent
patency for a long time. However, its invasiveness is
aﬄicted with complications and a less-invasive alternative
is preferable. Duplex sonography of arteries is completely
noninvasive but it is operator-dependent and not commonly
available for all body regions (e.g., renal or intracranial
arteries) [3].
Spiral computed tomography angiography (CTA) is a
noninvasive method to evaluate peripheral arteries and has
been shown to be an alternative to intra-arterial DSA in
diﬀerent studies [4, 5]. Drawbacks of CT are the need of a
potentiallynephrotoxiciodinecontrastmaterialandionizing
radiation.
Three-dimensional (3D) contrast enhanced MR angiog-
raphy (MRA) is another established noninvasive method to
examine peripheral arteries. This method has been shown
to be a promising noninvasive alternative to DSA and CTA
for screening patients suspected of having lower extremity
ischemia [6, 7]. However, MRA of stented arteries show
diﬃculties due to imaging artifacts that may obscure the
stent lumen [8–10]. Hamer et al. concluded that MRA is
not yet a reliable technique to characterize in-stent restenosis
because of high discrepancies between grading of lumen
narrowing on DSA and MRA [11]. The magnitude of
artifacts largely depends on the underlying stent type [12],2 Radiology Research and Practice
and in the last several years new stent types appeared on the
market that have not yet been evaluated for their MR lumen
visibility.
Therefore, the purpose of this study was to evaluate the
visibility and potential artifacts of diﬀerent arterial stents in
contrast to enhanced MRA in an experimental setting.
2.MaterialandMethods
2.1. Evaluated Stents and Experimental Setup. Twenty-one
diﬀerent stents and one stentgraft of diﬀerent material
and design were studied. Manufacturer, material, design,
length, and nominal diameter of the stents and stentgraft
are summarized in Table 1. Ten stents were made of nitinol,
seven of stainless surgical steel (316L), two of a cobalt-based
alloy, two of tantalum, and one of a platinum alloy. The
Wallgraft Endoprothesis is a Wallstent made of a cobalt-
based alloy covered with polyethylene (PET).
The stents and the stentgraft were implanted into plastic
tubes with 5, 7, 8, 10, or 13mm inner diameter depending
on their nominal diameter with one exception. The Palmaz
Genesis Stent had a nominal diameter of 6mm and was
implanted into a 5mm plastic tube. The wall of the small
tubes (5, 7, and 8mm) had a thickness of <0.3mm whereas
the wall of the large tubes (10 and 13mm) was about 1mm
thick.
The tubes were introduced into plastic boxes which
were ﬁlled with a solid gel (Dubliplast, Dentaurum AG,
Pforzheim, Germany) which has a relaxivity similar to that
of muscular tissue in the body [13]. The tubes were ﬁlled
with gadopentetate dimeglumine (Magnevist, Schering AG,
Berlin, Germany) in water at a concentration of 25mmol/L
(1:20 dilution of the standard preparation) and closed
at both ends. All images were acquired on a 1.5T MR
system (Achieva 1.5T, Philips, Best, The Netherlands). The
phantom was positioned in the center of the magnet with an
orientation parallel to the z-axis of the scanner. MR signal
was obtained with a 5 element-phased array cardiac coil.
2.2. MR Imaging Parameters. We performed localizing
sequences in three orthogonal planes. As MRA sequence
we used a short 3D T1-weighted spoiled gradient-echo
(T1-FFE) MRA sequence with the following parameters:
TR = 3.4ms, TE = 1.65ms, Flip angle = 30◦,ﬁ e l do f
view (FOV) = 290 × 200 × 50mm, genuine voxel size =
1 × 1 × 1mm, reconstructed voxel size = 0.55 × 0.55 ×
0.55mm, reconstruction matrix = 528 × 528, CLEAR (=
Constant LEvel AppeaRance, Philips Medical Systems, Best,
The Netherlands) = yes (for global image homogeneity
correction based on coil sensitivity determination), and NSA
= 2. Parallel acquisition techniques were not used. This
sequence is a standard sequence clinically used for MRA of
theperipheralvesselsandnotspeciﬁcallyadaptedtoimprove
stent visibility as proposed by previous studies [14, 15].
2.3. Image Analysis and Stent Evaluation.
(1) Image analysis was performed for all examined
stents. Longitudinal maximum intensity projections
(MIPs) were created for demonstration purposes
only (Figure 1). For each stent, the middle slice inter-
secting the center of the stent parallel to its longitu-
dinal axis was evaluated. Artifacts may obscure stent
lumen in three diﬀerent ways. The signal intensity
may be decreased, the lumen may appear stenosed,
and the signal intensity may be inhomogeneous.
Therefore, every stent has been evaluated in the
following categories: (1) Loss of signal intensity, (2)
lumen narrowing, and (3) homogeneity of the lumen
signal. For every category a grading was performed:
good (score 3), intermediate (score 2), and poor
(score 1) results.
For quantitative comparison of stent artifacts and lumen
visibility, the loss of signal intensity was quantiﬁed by
measuring the signal intensity inside the stented lumen
and comparing it with the signal intensity in the unstented
tube, calculating percent intensity. For the visualization of
stents and for the possibility to detect stenoses a high-signal
intensity inside the stent lumen is required. Therefore, we
deﬁned the following grading for the results of the signal
intensity measurement: poor (1 point) <40%, intermediate
(2 points) 40%–60%, and good (3 Points) >60%.
Furthermore, the visible lumen diameter inside the
stented lumen was compared to the unstented vessel. To
determine the lumen narrowing, we measured the maximal
and the minimal diameter of the visible stent lumen. For
our evaluation we focused on the minimal visible lumen
diameterbecauseifastenosisislocatedatthatpositioninthe
stent it can only be detected when there is even further loss
of signal intensity than already caused by the static artifacts
of a stent which is independent of lumen narrowing caused
by a stenosis.
Regarding lumen narrowing, we deﬁned the following
grading: poor (1 point) <40%, intermediate (2 points) 40%–
70%, and good (3 points) > 70%.
The homogeneity of the signal intensity within the
stented lumen was measured by deﬁning a standardized
region of interest (ROI) with a size of 120 pixels inside
the stented lumen. We measured the standard deviation
(SD) of the lumen signal and divided it by the mean
intensity within the ROI to receive a numerical value of
the homogeneity of the signal intensity. Based on these
measurements, we deﬁned the following grading: poor (1
point)≥0.4,intermediate(2points)<0.4and≥0.1,andgood
(3 points) <0.1.
For the overall evaluation of the stent, the score of these
three categories were summarized and resulted in an overall
score between 3 and 9 with the following meaning: 3-4 poor,
5–7 intermediate, and 8-9 good.
3. Results
3.1. Signal Intensity. The signal intensities of the diﬀerent
stents are shown in Table 2. The relative signal intensity
compared to the unstented tube ranged between 6% (Palmaz
Genesis) and 117% (Wallstent Uni).Radiology Research and Practice 3
Table 1: Name, manufacturer, material, primary area of use, diameter, and length of the examined stents.
No. Name Manufacturer Material Primary area of use Diameter
(mm) Length (mm)
1 SAXX Small Devon 316L Arterial vessels 5 17
2 SelfX Xpert Abbott nitinol Peripheral vasculature/biliary duct 5 20
3 Palmaz
Genesis Cordis 316L Peripheral arteries below aortic arch/biliary
tree 63 9
4 Absolute Guidant nitinol Biliary/peripheral vessels 7 60
5 AccuLink





Scientiﬁc 316L Peripheral vessels 7 37
7 OmniLink
0,018 Guidant 316L Biliary/peripheral arteries 7 18
8 OmniLink
0,035 Guidant 316L Biliary/peripheral arteries 7 35
9 Palmaz
Corinthian IQ Cordis 316L Peripheral vessels 7 40
10 Renal109 Abbott tantalum Renal artery 7 18
11 Renal137 Abbott tantalum Renal artery 7 18
12 Sentinol Boston
Scientiﬁc nitinol Peripheral vessels 7 59
13 Symphony Boston
Scientiﬁc nitinol Iliac artery 7 40
14 Vascuﬂex SE B. Braun nitinol Peripheral vessels 7 20
15 Wallstent Uni Boston
Scientiﬁc cobalt-superalloy Iliac artery, sfa (superﬁcial femoral artery),
tracheal 76 0
16 Zilver Cook nitinol Carotid artery 7 40
17 Evo pfm nitinol Pelvic arteries and peripheral vessels/biliary 8 50
18 RxCarotid Abbott nitinol Carotid artery 8 30
19 SAXX Large Devon 316L Arterial vessels 8 35






bonded to the outside
of a Wallstent
(cobalt-superalloy)
Trachea/bronchus (oﬀ label: peripheral
arteries) 10 70
22 CP Stent pfm 90% platinum 10%
iridium Aorta 13 28
After grading of the signal intensity, 6 stents were clas-
siﬁed in the good group (3x nitinol, 2x tantalum, 1x cobalt
superalloy), 8 stents in the intermediate group (5x nitinol,
2x 316L, 1x stentgraft of PET, and cobalt superalloy), and 8
stents in the poor group (2x nitinol, 5x 316L, 1x platinum
alloy).
3.2. Lumen Narrowing. The lumen visibility with respect to
artiﬁcial lumen narrowing of the examined stents is shown
in Table 2.
In 4 stents we found a pattern of artifacts which results in
atruncationofthesignalofthestentlumen(PalmazGenesis,
Express Vascular LD, Palmaz Corinthian IQ and SAXX
Large, all made from 316L). The other stents showed visible
lumen diameters between 27% (SAXX small) and 92%
(Evo target).
After grading the magnitude of artiﬁcial lumen nar-
rowing for each stent, 7 stents were categorized in the
good group (4x nitinol, 1x tantalum, 1x stentgraft PET
+ cobalt superalloy, 1x platinum alloy), 11 stents in the
intermediate group (6x nitinol, 1x tantalum, 2x 316L, 1x
cobalt superalloy) and 5 stents in the poor group (5x 316L).
3.3. Lumen Homogeneity. The lumen homogeneity of the
stents is shown in Table 2. We classiﬁed 6 stents in the good
group (4x nitinol, 1x cobalt superalloy, 1x tantalum), 10
stents in the intermediate group (5x nitinol, 1x tantalum, 2x
316L, 1x PET + cobalt superalloy, 1x platinum alloy), and 6
stents in the poor group (1x nitinol, 5x 316L).
3.4. Overall Lumen Visibility Results. The overall lumen
visibility results are shown in Table 3. 7 stents exhibited4 Radiology Research and Practice
















1 SAXX Small 7 1 27 1 0.43 1
2 SelfX Xpert 62 3 58 2 0.11 2
3 Palmaz Genesis 6 1 0 1 0.44 1
4 Absolute 80 3 69 2 0.06 3
5 AccuLink
Carotid 57 2 69 2 0.10 2
6 Express Vascular
LD 21 1 0 1 0.48 1
7 OmniLink 0,018 46 2 38 2 0.33 2
8 OmniLink 0,035 45 2 51 2 0.21 2
9 Palmaz
Corinthian IQ 12 1 0 1 0.42 1
10 Renal109 66 3 72 3 0.16 2
11 Renal137 69 3 58 2 0.07 3
12 Sentinol 51 2 89 3 0.04 3
13 Symphony 15 1 60 2 0.35 2
14 Vascuﬂex SE 42 2 80 3 0.09 3
15 Wallstent Uni 117 3 60 2 0.08 3
16 Zilver 66 3 66 2 0.07 3
17 Evo 45 2 80 3 0.19 2
18 RxCarotid 10 1 65 2 0.81 1
19 SAXX Large 7 1 0 1 0.40 1
20 Evo Target 43 2 92 3 0.16 2
21 Wallgraft
Endoprothesis 52 2 75 3 0.16 2
22 CP Stent 21 1 86 3 0.14 2
overall a good lumen visibility in the contrast-enhanced
MRA examination (4x nitinol, 2x tantalum, 1x cobalt
superalloy): Absolute (nitinol), Renal 109 (tantalum), Renal
137 (tantalum), Sentinol (nitinol), Vascuﬂex SE (nitinol),
Wallstent Uni (cobalt superalloy), and Zilver (nitinol). Fur-
thermore, 9 stents showed intermediate results (5x nitinol,
2x 316L, 1x PET + cobalt superalloy, 1x platinum alloy) and
6 stents showed poor results (1x nitinol, 5x 316L).
4. Discussion
In the present study several diﬀerent peripheral stents were
examined in an MRI scanner with current electronics and
gradient performance to evaluate their lumen visibility using
magnetic resonance angiography (MRA) with a gadolinium-
based contrast agent.
The investigated stents are made from diﬀerent materials
(stainless steel (316L), nitinol, cobalt superalloy, tantalum,
and platinum-iridium alloy) and for diﬀerent areas of
application(arterialandperipheralarteriesingeneral,biliary
duct, carotid arteries, renal arteries, iliac arteries, femoral
arteries, and the aorta). Independent from the area of inser-
tion, follow-up examinations are necessary to determine the
interventional success and exclude complications or resteno-
sis. Contrast-enhanced MRA is one possible noninvasive
modality for follow-up examinations and our study shows
what to expect from this technique with a current MRI
scanner and diﬀerent stents.
A systematic explanation of the imaging features mea-
sured in this study is diﬃcult. Signal intensity, signal
homogeneity, and lumen narrowing are dependent on both,
susceptibility and RF artifacts of the objects. The magnetic
susceptibility diﬀerence between stent material and tissue
causes local variations of the B0 ﬁeld in the tissue adjacent
to the stent material (which itself gives no signal). The ﬁeld
inhomogeneity results in misregistration of an acquired sig-
nal to a false position. In spin-echo images this causes bright
spots adjacent to signal voids, while imaging with gradient
echo techniques as in MR angiography causes additional
signallossintheareaoflocalﬁeldinhomogeneities,resulting
in larger signal voids, which may also mask the bright spots
visible in spin-echo imaging [16, 17]. Shape and extent ofRadiology Research and Practice 5
Table 3: Overall results.





homogeneity Overall Score Overall
Evaluation
1 S A X X S m a l l 1113 P o o r
2 SelfX Xpert 3 2 2 7 Intermediate
3 Palmaz Genesis 1 1 1 3 Poor
4 A b s o l u t e3238 G o o d
5 AccuLink
Carotid 2 2 2 6 Intermediate
6 Express Vascular
LD 1113 P o o r
7 OmniLink 0.018 2 2 2 6 Intermediate
8 OmniLink 0.035 2 2 2 6 Intermediate
9 Palmaz
Corinthian IQ 1113 P o o r
10 Renal109 3 3 2 7 Good
11 Renal137 3 2 3 8 Good
12 Sentinol 2 3 3 8 Good
13 Symphony 1 2 2 5 Intermediate
14 Vascuﬂex SE 2 3 3 8 Good
15 W a l l s t e n t U n i 3238 G o o d
16 Z i l v e r 3238 G o o d
17 Evo 2 3 2 7 Intermediate
18 R x C a r o t i d 1214 P o o r
19 S A X X L a r g e 1113 P o o r
20 Evo Target 2 3 2 7 Intermediate
21 Wallgraft
Endoprothesis 2 3 2 7 Intermediate
22 CP Stent 1 3 2 6 Intermediate
susceptibility artifacts at a speciﬁc nominal ﬁeld depend on
the susceptibility of the stent material, the orientation of the
stents relative to the B0 ﬁeld, to the direction of frequency
encoding (or phase encoding in the case of EPI), and to
acquisition bandwidth.
With a ﬁxed imaging protocol, larger susceptibility
artifactsaretobeexpectedforlargersusceptibilitydiﬀerences
betweentissueandstent.Fortantalum,nitinol,andplatinum
these diﬀerences are about 190 · 10
−6, 255 · 10
−6 and 290 ·
10
−6, respectively (ﬁeld units in SI, [18]), for nonmagnetic
steel 316L in the order of 10
−3 to 10
−2.D i ﬀerences of
susceptibilitiesindiﬀerenttissues(muscle,marrow,liver)are
below 10 · 10
−6 and in general negligible for imaging. Thus,
for stents of equal geometry the size of artifacts increases in
the order of tantalum, nitinol, platinum, steel, but this order
may be changed depending on mass and conﬁguration of the
wire.
Another source of artifacts are radio frequency artifacts
[19]. As stents are conductive structures, eddy currents
throughthestrutsofthestentsoccurduringRFpulses,which
cause a local shielding of B1, especially in the stent lumen.
The actual B1 value strongly depends on the conﬁguration of
the wires in the stent. A local decrease of the B1 ﬁeld results
in a locally decreased excitation angle. In addition, the local
B1 decrease is accompanied by decreased local signal uptake.
A smaller pulse angle leads to an altered signal excitation; it
canbeincreased,evenhigherthanthesignaloutsidethestent
[15], if the image is T1 weighted and the lower pulse angle
causes less saturation, that is, is nearer to the Ernst angle (see
stent 15, Table 2). Otherwise the excitation is decreased.
Therefore, as imaging features of stents are aﬀected by
various parameters of the material and conﬁguration and a
systematicpredictionofartifactsofaspeciﬁcstentisdiﬃcult,
an individual assessment of stent imaging characteristics is
necessary.
Using the modus of result evaluation with classiﬁcation
into three categories of stent visibility our study provides
referencesonwhichstentsareeligibleforMRAexaminations
and which products should be examined with other tech-
niques such as computed tomography angiography (CTA) or
conventional intra-arterial digital subtraction angiography
(DSA). In CTA, the magnitude of stent-related artifacts
is correlated to the atomic number of the stent material
(platinum (78), tantalum (73), nickel (28), cobalt (27), steel
(26), and chromium (24)). It has been shown before [12]
that stents which are not eligible for MRA examinations
qualify good for CTA examinations and vice versa. Steel
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Figure 1: Comparison of 22 diﬀerent peripheral arterial stents. Longitudinal MIP reformations are shown.
CTA while tantalum stents show good results in MRA and
bad results in CTA.
With information about the imaging results of diﬀerent
peripheral stents in diﬀerent examination techniques, the
clinical radiologist can decide which technique is suitable for
a follow-up examination of his patient.
The phantom used was designed to simulate conditions
comparable to an in vivo MRI examination. Nevertheless,
some limitations have to be considered. In our scans the
stents were positioned parallel to the z-axis of the scanner.
This would ﬁt to the position of an aortic stent but not
to renal or iliac stents. In other studies it has been shown
that the artifacts caused by the stents depend on the angle
between stent and the z-axis of the magnetic ﬁeld [8, 14].
We used a static ﬂuid model without ﬂow within the
stents. The eﬀect on the characteristics of the artifact
expression is assumed to be negligible because we used
an MRA protocol with a gadolinium-based contrast agent,
which measures the T1 diﬀerences of the materials and does
not depend on the ﬂow, in contrast to MRA examinations
without contrast enhancement as Time of Flight or Phase
Contrast techniques.
Software algorithms like CLEAR for data postprocessing
have been released to further improve image quality and
reduce contrast inhomogeneities caused by parallel image
acquisition. Thus, these data modiﬁcation algorithms may
have inﬂuence on SI measurements and therefore hamper
SNR/CNR calculation.
However, a recent study conﬁrmed, that SI and SD
measurements performed within the examined object are
applicable in data sets reconstructed with a CLEAR-based
algorithm and SNR/CNR calculations are valid [20].
We performed our scans in a 1.5T MRI scanner. Other
studies [21, 22] have shown that similar results can be
expected from scans in a 3.0T MRI scanner. There might be
a higher signal-to-noise ratio and larger area of signal void
surroundingthestentsat3.0Tcomparedto1.5T,butafterall
it seems likely that good stents at 1.5T MRA will still belong
to the better ones at 3.0T MRA, and bad stents at 1.5T MRA
will also be worse at 3.0T.Radiology Research and Practice 7
Our catalogue of the examined stents is not complete.
Some of the currently available stents have not been included
in this study, others have been investigated in previous
studies [10, 12, 21]. Nevertheless, we examined stents of
diﬀerent materials, sizes, and designs so that our results can
be transferred to similar products on the market.
I ns u m m a r y ,t a n t a l u ms t e n t ss e e mt ob em o s ts u i t a b l e
for MRA examinations. Stents made from a cobalt alloy
or nitinol are still suitable for MRA examinations but they
cause more artifacts than tantalum stents and it depends
on their individual stent design if small stenoses can be
detected. Stents made from stainless steel (316L) show the
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